Glenmark to conduct trials of potential Covid drug

Glenmark Pharmaceuticals on Thursday said it has become the first company in India to receive approval from DCGI to conduct clinical trials of Favipiravir antiviral tablets to treat COVID-19 patients. Having internally developed the API and the formulations for the product, the company received approval for conducting the trial on mild to moderate patients.



April 30, 2020 at 11:01AM